Healthcare Sector Review: Winning and Losing Stocks on Oct 18th

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • Halozyme Therapeutics (NASDAQ:HALO): The shares closed at $7.35, up $1.15, or 18.55%, on the day. Its market capitalization is $761.60 million. About the company: Halozyme Therapeutics, Inc. develops and commercializes recombinant human enzymes for the infertility, ophthalmology, and oncology communities. The Company’s product portfolio is based on intellectual property covering the family of human enzymes known as hyaluronidases. Halozyme’s products offer an alternative to slaughterhouse-derived extracts that carry contamination risks.
  • Human Genome Sciences (NASDAQ:HGSI): The shares closed at $12.82, up $1.57, or 13.96%, on the day. Its market capitalization is $2.44 billion. About the company: Human Genome Sciences, Inc. researches and develops proprietary pharmaceutical and diagnostic products. The Company’s products predict, prevent, detect, treat, and cure disease based on the discovery of human and microbial genes.
  • Senomyx Inc. (NASDAQ:SNMX): The shares closed at $3.86, up $0.45, or 13.2%, on the day. Its market capitalization is $153.00 million. About the company: Senomyx, Inc. discovers new proprietary flavor and fragrance molecules for use in a wide range of consumer products. The company’s flavor and fragrance molecules are used by consumer products companies to improve the taste or smell of many products, including processed foods, beverages, perfumes and personal and home care products.
  • Metabolix, Inc. (NASDAQ:MBLX): The shares closed at $5.12, up $0.55, or 12.04%, on the day. Its market capitalization is $174.50 million. About the company: Metabolix, Inc. produces biobased, biodegradable, natural plastics and chemicals.
  • GTx, Inc. (NASDAQ:GTXI): The shares closed at $4.22, up $0.39, or 10.18%, on the day. Its market capitalization is $264.84 million. About the company: GTx, Inc. discovers, develops, and commercializes therapeutics primarily related to the treatment of serious men’s health conditions. The Company’s drug discover and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens, two essential classes of hormones. GTx is currently developing products for prostate cancer.

Losers (% price change)

  • Hospira, Inc. (NYSE:HSP): The shares closed at $29.51, down $7.85, or 21.01%, on the day. Its market capitalization is $4.87 billion. About the company: Hospira, Inc. is a global specialty pharmaceutical and medication delivery company. The Company’s product portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems.
  • Sequenom, Inc. (NASDAQ:SQNM): The shares closed at $4.93, down $0.63, or 11.33%, on the day. Its market capitalization is $488.95 million. About the company: Sequenom Inc. is a molecular diagnostic testing and genetics analysis company. The Company provides services, diagnostic testing, applications and genetic analysis products. Sequenom’s products translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural, livestock, and other areas of research.
  • Regeneron Pharmaceuticals (NASDAQ:REGN): The shares closed at $60.49, down $4.14, or 6.41%, on the day. Its market capitalization is $5.54 billion. About the company: Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders.
  • Jazz Pharmaceuticals, Inc (NASDAQ:JAZZ): The shares closed at $40.34, down $2.68, or 6.23%, on the day. Its market capitalization is $1.68 billion. About the company: Jazz Pharmaceuticals, Inc. develops and markets treatments for neurological and psychiatric conditions. The Company produces treatments for cataplexy, excessive daytime sleepiness, and ethylene glycol and methanol poisoning in humans.
  • Hi-Tech Pharmacal Co. (NASDAQ:HITK): The shares closed at $32.50, down $1.16, or 3.45%, on the day. Its market capitalization is $414.28 million. About the company: Hi-Tech Pharmacal Co., Inc. manufactures prescription and over-the-counter generic and branded pharmaceuticals in liquid and semi-solid dosage forms. The Company also manufactures sterile ophthalmic, otic, and inhalation products and provides sterile manufacturing contract services. Hi-Tech markets its own products under names such as H-T, Rx Choice, DiabetiDerm, and Steri-Optics.

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet